{"status":"OK","data":{"advertisement":{"id":292682,"title":"Request for quotation no. 27 03 2025 WN - Granting of access to the license of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling software.","partial_offer_allowed":false,"publication_date":"2025-03-27","submission_deadline":"2025-04-03 23:59:59","planned_sign_date":"2025-04-01","supplementary_orders":null,"terms_of_contract_change":"VIII.3.\tThe Ordering Party provides for the possibility of amending the terms of the contract concluded as a result of this procedure:\na.\tRenewal of the License Period - the Ordering Party reserves the right to renew the License for additional years during the Project. Before the end of the current license period, the Ordering Party will ask the Supplier for the quotation for the following year. The Ordering Party reserves the right to renew the license if the price for the following year does not exceed the price for the current year by more than 15%. During renewal, the number and type of licenses may change.\nb.\tForce Majeure - the Ordering Party reserves the right to amend the terms of the contract concluded as a result of this procedure also in the event of the occurrence of force majeure understood as an event that substantially impedes the performance of obligations under the grant contract, which the parties could not have foreseen and which they could not have prevented or overcome by acting with due diligence.","created_at":"2025-03-27 15:57:33","modified_at":"2025-04-04 00:00:27","contact_persons":[{"id":57,"forename":"Aleksandra","surname":"Mazga\u0142a","phone_number":"+48 538 899 945","email":"tenders@ryvu.com","created_by":null,"created_at":"2026-11-06 17:43:17","modified_at":"2026-11-06 17:43:17","modified_by":null}],"orders":[{"id":475270,"estimated_value":null,"order_items":[{"id":536287,"description":"Part of the contract: Part 1\nName and CPV code:  48461000-7 Analytical or scientific software package.\nGranting of access to the license of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling software.\n\nThe contractor should provide the license for scientific software for compartmental (CA) and non-compartmental analysis (NCA), pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic (TK) modelling and simulation as described below.\nThe minimum set of functionalities: \na)\tCriteria settings for calculations\nb)\tAcceptance criteria settings for quality control\nc)\tDefinition of custom parameters \nd)\tCustomization of workflows and PK/PD models\ne)\tEditing of plots, figures and tables\nf)\tTool provides automated calculation of NCA ratio\ng)\tUser-defined NCA parameters\nh)\tUser-friendly software providing modelling, statistical, graphical and data management tools\ni)\tIncludes libraries of PK/PD models and workflows\nj)\tPossible to lock workflow templates with password protection\nk)\tPost-purchase user support (online training, webinars, etc.)\t\nl)\tCompatible with Windows       \nLicense type: Annual named user license\nLicense term: 1 year, with the possibility of renewing the license for additional years during the duration of the Project.\nQuantity: 3 licenses - 2 with basic options as described above and 1 license additionally with a software validation tool, including a plugin enabling the execution of the following actions: \na) Customizable population PK and PKPD analysis tool\nb) Non-linear mixed effects pharmacokinetic modelling and simulation software.\n","warranty_period":null,"cpv_items":[{"id":7258,"code":"48461000-7","name":"Analityczne lub naukowe pakiety oprogramowania"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2025-03-27 15:57:33","modified_at":"2025-03-27 15:57:33","modified_by":null,"id":605381,"type":{"id":1,"name":"adres"},"group_uuid":"bdc702d7-e7b6-482e-a20f-b9a86091a508"}],"participation_conditions":[{"id":1495598,"description":"Due to the prohibition of conflicts of interest, Contractors with personal or capital ties to the Ordering Party are excluded from the procedure. Equity or personal relationship is understood as relations between the Ordering Party or individuals authorized to take commitments on behalf of the Ordering Party or those acting on behalf of the Ordering Party in order to prepare and implement the contractor selection procedure, and the Contractor, including in particular:\na.\tparticipation in a company as a partner in a civil law partnership or a partnership, holding at least 10% of shares (unless a lower threshold is specified by law), being a member of a supervisory or managerial body, a proxy, a proxy, \nb.\tthey are married, in a relationship of kinship or affinity in a straight line, or in a relationship of kinship or affinity in the collateral line to the second degree, or in a relationship of adoption, custody or guardianship, or in a shared life relationship with the economic operator, its legal deputy, or members of the management or supervisory bodies of contractors applying for the award of the contract, \nc.\tthey have such a legal or factual relationship with the economic operator that there is a reasonable doubt as to their impartiality or independence in connection with the contract award procedure.\nAssessment of the fulfillment of the above-mentioned condition will be made on the basis of a declaration of the Ordering Party.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2025-03-27 15:57:33","modified_at":"2025-03-27 15:57:33","modified_by":null,"group_uuid":"7cf802bc-6801-43b0-b6ac-05a289e30926"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":5,"name":"Us\u0142ugi IT"},"created_by":null,"created_at":"2025-03-27 15:57:33","modified_at":"2025-03-27 15:57:33","modified_by":null,"group_uuid":"1d96bdb5-fcd8-4a05-9cb7-1c3bd7d2d375"}],"evaluation_criteria":[{"id":836638,"price_criterion":true,"description":"Price 100%","created_by":null,"created_at":"2025-03-27 15:57:33","modified_at":"2025-03-27 15:57:33","modified_by":null,"group_uuid":"1963b140-7359-4712-8e75-600d59f95611"}],"is_variant":false,"title":"License of pharmacokinetic and pharmacokinetic-pharmacodynam","order_node":{"id":359992},"created_by":null,"created_at":"2025-03-27 15:57:33","modified_at":"2025-03-27 15:57:33","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":{"id":112,"contact_persons":[]},"created_at":"2025-03-27 15:57:33","modified_at":"2025-03-27 15:57:33","modified_by":{"id":112,"contact_persons":[]},"id":810524,"street":"Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2025-03-27 15:57:33","modified_at":"2025-03-27 15:57:33","modified_by":{"id":112,"contact_persons":[]},"id":293460},"advertisement":{"id":222117,"number":"2025-112-222117","publication_date":"2025-03-27","created_by":{"id":112,"contact_persons":[]},"created_at":"2025-03-27 15:16:38","modified_at":"2025-04-04 00:00:27","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[292653,292682],"enrollment":{"id":55990,"name":"\u015acie\u017cka SMART - Priorytet 1 \u201eWsparcie dla przedsi\u0119biorc\u00f3w\u201d - Fundusze Europejskie dla Nowoczesnej Gospodarki 2021-2027","number":"001/24","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-001/24","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2025-02-07 15:18:18","modified_at":"2025-02-07 15:18:18","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":292682,"publication_date":"2025-03-27"},"id":1741508,"name":"RFQ 27 03 2025 WN","file":{"id":1939731,"name":"RFQ 27 03 2025 WN.pdf","created_at":"2025-03-27 15:57:08","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1939731"},"group_uuid":"fbde19df-3faf-4b06-90f7-f5075304d78b"},{"origin":{"id":292682,"publication_date":"2025-03-27"},"id":1741509,"name":"OFFER FORM TO RFQ 27 03 2025 WN","file":{"id":1939733,"name":"OFFER FORM TO RFQ 27 03 2025 WN.docx","created_at":"2025-03-27 15:57:23","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1939733"},"group_uuid":"8409fb76-c65d-47f8-bb1c-10b45baf43ce"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}